Metagenomi Therapeutics Growth Metrics (2023-2026) | MGX

Growth Metrics Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Growth Ratios
EBITDA Margin Growth (1y) (Quarter) -4087.006,268.001,324.00-9955.00-38186.00-18317.00-8902.00-32581.00-126319.00
EBITDA Margin Growth (3y) (Quarter) -168592.00
EBITDA Margin (QoQ) (Quarter) 6,982.00-4346.00625.00-7349.0017,337.00-9290.00-10654.00-35580.0037,207.00126.00-34333.00-129318.00
EBIT Margin Growth (1y) (Quarter) -5296.007,416.00-1325.00-5163.00-41393.00-16225.00-6936.00-40853.00-129601.00
EBIT Margin Growth (3y) (Quarter) -176290.00
EBIT Margin (QoQ) (Quarter) 4,876.00-2270.001,826.00-9728.0017,589.00-11012.00-2011.00-45959.0042,757.00-1723.00-35928.00-134707.00
EBT Margin Growth (1y) (Quarter) -6438.003,333.00-3077.00-12232.00-37898.00-16867.00-5688.00-31921.00-124254.00
EBT Margin Growth (3y) (Quarter) -168590.00
EBT Margin (QoQ) (Quarter) 6,298.00-5256.001,694.00-9174.0016,070.00-11667.00-7460.00-34840.0037,100.00-488.00-33693.00-127173.00
Enterprise Value Growth (1y) (Quarter) -242.21%-480.70%-169.48%8.44%30.98%31.65%32.95%35.24%37.97%
Enterprise Value Growth (3y) (Quarter) -13.57%
Enterprise Value (QoQ) (Quarter) 46.02%-97.29%-166.13%-20.73%8.39%8.45%9.57%9.00%9.28%10.19%12.66%12.83%
FCF Margin Growth (1y) (Quarter) -236.008,831.002,013.00-12279.00-28476.00-11437.00-2154.00-31200.00-113826.00
FCF Margin Growth (3y) (Quarter) -142538.00
FCF Margin (QoQ) (Quarter) 5,267.00-2372.006,430.00-9561.0014,334.00-9190.00-7862.00-25757.0031,373.0093.00-36908.00-108384.00
Net Margin Growth (1y) (Quarter) -3900.006,107.00-273.00-8776.00-38135.00-18018.00-7247.00-33264.00-124096.00
Net Margin Growth (3y) (Quarter) -166132.00
Net Margin (QoQ) (Quarter) 7,162.00-4558.00471.00-6975.0017,169.00-10937.00-8033.00-36334.0037,286.00-166.00-34050.00-127166.00
Operating Margin Growth (1y) (Quarter) -5296.007,416.00-1325.00-5163.00-41393.00-16225.00-6936.00-40853.00-129601.00
Operating Margin Growth (3y) (Quarter) -176290.00
Operating Margin (QoQ) (Quarter) 4,876.00-2270.001,826.00-9728.0017,589.00-11012.00-2011.00-45959.0042,757.00-1723.00-35928.00-134707.00
Return on Assets Growth (1y) (Quarter) 0.000.000.000.000.00
Return on Assets (QoQ) (Quarter) 0.000.000.000.000.000.000.000.00
Return on Capital Employed Growth (1y) (Quarter) -427.00-1102.00-1292.00-1615.00-1742.00
Return on Capital Employed (QoQ) (Quarter) 261.00-166.00-212.00-309.00-414.00-356.00-535.00-436.00
Return on Equity Growth (1y) (Quarter) -1.001.000.000.000.000.00
Return on Equity (QoQ) (Quarter) -2.001.000.000.000.000.000.000.000.00
Return on Invested Capital Growth (1y) (Quarter) -2.001.000.000.000.000.00
Return on Invested Capital (QoQ) (Quarter) -3.001.000.000.000.000.000.000.000.00
Return on Sales Growth (1y) (Quarter) -1.001.000.00-1.00-4.00-2.00-1.00-3.00-12.00
Return on Sales Growth (3y) (Quarter) -17.00
Return on Sales (QoQ) (Quarter) 0.000.000.00-1.002.00-1.00-1.00-4.004.000.00-3.00-13.00